Role of Toll-like receptors in gastrointestinal malignancies (original) (raw)

• Abreu MT, Fukata M, Arditi M . (2005). TLR signaling in the gut in health and disease. J Immunol 174: 4453–4460.
  CAS PubMed Google Scholar
• Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M . (2001). Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609–1616.
  CAS PubMed Google Scholar
• Arber N, Eagle CJ, Spicak J, Racz I, Dite P, Hajer J et al. (2006). Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355: 885–895.
  CAS PubMed Google Scholar
• Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E . (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172: 2522–2529.
  CAS PubMed Google Scholar
• Atherfold PA, Jankowski JA . (2006). Molecular biology of Barrett's cancer. Best Pract Res Clin Gastroenterol 20: 813–827.
  CAS PubMed Google Scholar
• Balkwill F, Coussens LM . (2004). Cancer: an inflammatory link. Nature 431: 405–406.
  CAS PubMed Google Scholar
• Baoprasertkul P, Peatman E, Abernathy J, Liu Z . (2007). Structural characterisation and expression analysis of Toll-like receptor 2 gene from catfish. Fish Shellfish Immunol 22: 418–426.
  CAS PubMed Google Scholar
• Bernstein CN, Eaden J, Steinhart AH, Munkholm P, Gordon PH . (2002). Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 8: 356–361.
  PubMed Google Scholar
• Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K et al. (2006). Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355: 873–884.
  Article CAS PubMed Google Scholar
• Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M et al. (2006). Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin Genet 70: 156–160.
  CAS PubMed Google Scholar
• Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J et al. (2005). The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis 11: 645–652.
  PubMed Google Scholar
• Brittan M, Wright NA . (2002). Gastrointestinal stem cells. J Pathol 197: 492–509.
  PubMed Google Scholar
• Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF et al. (2007). Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 117: 258–269.
  CAS PubMed PubMed Central Google Scholar
• Cario E, Podolsky DK . (2000). Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010–7017.
  CAS PubMed PubMed Central Google Scholar
• Chamaillard M, Girardin SE, Viala J, Philpott DJ . (2003). Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5: 581–592.
  CAS PubMed Google Scholar
• Chang YJ, Wu MS, Lin JT, Sheu BS, Muta T, Inoue H et al. (2004). Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol Pharmacol 66: 1465–1477.
  CAS PubMed Google Scholar
• Choi PM, Zelig MP . (1994). Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35: 950–954.
  CAS PubMed PubMed Central Google Scholar
• Chung YC, Chang YF . (2003). Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 83: 222–226.
  PubMed Google Scholar
• Contasta I, Pellegrini P, Berghella AM, Del Beato T, Adorno D . (2006). Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy. Cancer Biother Radiopharm 21: 488–505.
  CAS PubMed Google Scholar
• Coussens LM, Werb Z . (2002). Inflammation and cancer. Nature 420: 860–867.
  CAS PubMed PubMed Central Google Scholar
• Derdak Z, Fulop P, Sabo E, Tavares R, Berthiaume EP, Resnick MB et al. (2006). Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-kappaB activation and oxidative stress. Carcinogenesis 27: 956–961.
  CAS PubMed Google Scholar
• de Visser KE, Coussens LM . (2005). The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 54: 1143–1152.
  CAS PubMed Google Scholar
• De Vita F, Romano C, Orditura M, Galizia G, Martinelli E, Lieto E et al. (2001). Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res 21: 45–52.
  CAS PubMed Google Scholar
• Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, Moser AR et al. (1997). Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res 57: 812–814.
  CAS PubMed Google Scholar
• Drewitz DJ, Sampliner RE, Garewal HS . (1997). The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92: 212–215.
  CAS PubMed Google Scholar
• Du X, Poltorak A, Wei Y, Beutler B . (2000). Three novel mammalian Toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11: 362–371.
  CAS PubMed Google Scholar
• Eaden JA, Abrams KR, Mayberry JF . (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526–535.
  CAS PubMed PubMed Central Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO . (1990). Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336: 357–359.
  CAS PubMed Google Scholar
• Engle SJ, Ormsby I, Pawlowski S, Boivin GP, Croft J, Balish E et al. (2002). Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 62: 6362–6366.
  CAS PubMed Google Scholar
• Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B et al. (2003). CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162: 691–702.
  CAS PubMed PubMed Central Google Scholar
• Farinha P, Gascoyne RD . (2005). Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 23: 6370–6378.
  CAS PubMed Google Scholar
• Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C et al. (2001). Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 48: 310–313.
  CAS PubMed PubMed Central Google Scholar
• Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R . (2001). Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42: 1337–1348.
  CAS PubMed Google Scholar
• Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T et al. (2004). Deficient host–bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987–992.
  CAS PubMed PubMed Central Google Scholar
• Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P et al. (2004). Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 10: 4015–4021.
  CAS PubMed Google Scholar
• Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS et al. (2006). Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862–877.
  CAS PubMed Google Scholar
• Fukata M, Chen A, Vamadevan AS, Choen J, Breglio K, Krishnareddy S et al. (2007). Toll-like receptor-4 (TLR4) promotes the development of colitis-associated colorectal tumors. Gastroenterology (in press).
• Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K et al. (2005). Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055–G1065.
  CAS PubMed Google Scholar
• Fukumoto S, Ichihara T, Takada M, Kuroda Y . (2003). Expression of cyclooxygenases in Helicobacter pylori gastritis and residual gastritis after distal gastrectomy. World J Surg 27: 145–148.
  PubMed Google Scholar
• Furrie E, Macfarlane S, Thomson G, Macfarlane GT . (2005). Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115: 565–574.
  CAS PubMed PubMed Central Google Scholar
• Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH et al. (1997). Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89: 1277–1284.
  CAS PubMed Google Scholar
• Garlanda C, Riva F, Veliz T, Polentarutti N, Pasqualini F, Radaelli E et al. (2007). Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res 67: 6017–6021.
  CAS PubMed Google Scholar
• Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A et al. (2005). Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11: 681–685.
  CAS PubMed PubMed Central Google Scholar
• Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285–296.
  CAS PubMed Google Scholar
• Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N . (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15: 1126–1131.
  CAS PubMed Google Scholar
• Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A et al. (2007). Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133: 1099–1105.
  PubMed Google Scholar
• Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC et al. (1988). Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29: 206–217.
  CAS PubMed PubMed Central Google Scholar
• Haselkorn T, Whittemore AS, Lilienfeld DE . (2005). Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16: 781–787.
  PubMed Google Scholar
• Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T et al. (2002). Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122: 1987–2000.
  CAS PubMed Google Scholar
• Helzlsouer KJ, Erlinger TP, Platz EA . (2006). C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 42: 704–707.
  CAS PubMed Google Scholar
• Hill MJ, Drasar BS, Hawksworth G, Aries V, Crowther JS, Williams RE . (1971). Bacteria and aetiology of cancer of large bowel. Lancet 1: 95–100.
  CAS PubMed Google Scholar
• Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA et al. (2007). A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132: 905–912.
  CAS PubMed Google Scholar
• Hope ME, Hold GL, Kain R, El-Omar EM . (2005). Sporadic colorectal cancer – role of the commensal microbiota. FEMS Microbiol Lett 244: 1–7.
  CAS PubMed Google Scholar
• Houghton J, Wang TC . (2005). Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128: 1567–1578.
  CAS PubMed Google Scholar
• Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH et al. (2005). Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65: 5009–5014.
  CAS PubMed Google Scholar
• Huang B, Zhao J, Shen S, Li H, He KL, Shen GX et al. (2007). Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 67: 4346–4352.
  CAS PubMed Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599–603.
  CAS PubMed Google Scholar
• Ishida I, Kubo H, Suzuki S, Suzuki T, Akashi S, Inoue K et al. (2002). Hypoxia diminishes Toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells. J Immunol 169: 2069–2075.
  CAS PubMed Google Scholar
• Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N et al. (2004). Essential role of MD-2 in TLR4-dependent signaling during _Helicobacter pylori_-associated gastritis. J Immunol 173: 1406–1416.
  CAS PubMed Google Scholar
• Itzkowitz SH, Harpaz N . (2004). Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126: 1634–1648.
  PubMed Google Scholar
• Itzkowitz SH, Yio X . (2004). Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7–G17.
  CAS PubMed Google Scholar
• Janne PA, Mayer RJ . (2000). Chemoprevention of colorectal cancer. N Engl J Med 342: 1960–1968.
  CAS PubMed Google Scholar
• Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M et al. (2001). Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 61: 2395–2398.
  CAS PubMed Google Scholar
• Kawahara T, Kuwano Y, Teshima-Kondo S, Kawai T, Nikawa T, Kishi K et al. (2001a). Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 48: 190–197.
  CAS PubMed Google Scholar
• Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K . (2001b). Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382–4389.
  CAS PubMed PubMed Central Google Scholar
• Kelly IM, Bartram CI . (1993). Pseudotumoral appearance of small bowel strictureplasty for Crohn's disease. Abdom Imaging 18: 366–368.
  CAS PubMed Google Scholar
• Kinoshita T, Ito H, Miki C . (1999). Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 85: 2526–2531.
  CAS PubMed Google Scholar
• Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y et al. (1996). Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307–317.
  CAS PubMed Google Scholar
• Langholz E, Munkholm P, Davidsen M, Binder V . (1992). Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103: 1444–1451.
  CAS PubMed Google Scholar
• Laqueur GL, Matsumoto H, Yamamoto RS . (1981). Comparison of the carcinogenicity of methylazoxymethanol-beta-D-glucosiduronic acid in conventional and germfree Sprague–Dawley rats. J Natl Cancer Inst 67: 1053–1055.
  CAS PubMed Google Scholar
• Leblond CP . (1964). Classification of cell populations on the basis of their proliferative behavior. Natl Cancer Inst Monogr 14: 119–150.
  CAS PubMed Google Scholar
• Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A et al. (2005). Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a−/− mice results in colitis that progresses to dysplasia. Am J Pathol 166: 1793–1806.
  CAS PubMed PubMed Central Google Scholar
• Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG et al. (2004). Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect Immun 72: 6446–6454.
  CAS PubMed PubMed Central Google Scholar
• Manju V, Nalini N . (2006). Effect of ginger on bacterial enzymes in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Eur J Cancer Prev 15: 377–383.
  CAS PubMed Google Scholar
• Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al. (2005). ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6: 587–592.
  CAS PubMed Google Scholar
• Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS et al. (2003). Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host–microbial interactions in the gut. J Immunol 170: 1406–1415.
  CAS PubMed Google Scholar
• Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR . (2001). Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 32: 449–453.
  CAS PubMed Google Scholar
• Nowacki MR . (1993). Cell proliferation in colonic crypts of germ-free and conventional mice – preliminary report. Folia Histochem Cytobiol 31: 77–81.
  CAS PubMed Google Scholar
• Ohara T, Morishita T, Suzuki H, Hibi T . (2006). Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of Toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas. Int J Mol Med 18: 59–63.
  CAS PubMed Google Scholar
• Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM et al. (2005). Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 11: 567–575.
  PubMed Google Scholar
• Otte JM, Cario E, Podolsky DK . (2004). Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054–1070.
  CAS PubMed Google Scholar
• Ouburg S, Mallant-Hent R, Crusius JB, van Bodegraven AA, Mulder CJ, Linskens R et al. (2005). The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut 54: 439–440.
  CAS PubMed PubMed Central Google Scholar
• Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS . (2004). Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173: 3589–3593.
  CAS PubMed Google Scholar
• Parkin DM, Pisani P, Ferlay J . (1999). Global cancer statistics. CA Cancer J Clin 49: 33–64.
  CAS PubMed Google Scholar
• Paulsen JE, Knutsen H, Olstorn HB, Loberg EM, Alexander J . (2006). Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice. Int J Cancer 118: 540–546.
  CAS PubMed Google Scholar
• Peek Jr RM, Blaser MJ . (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28–37.
  CAS PubMed Google Scholar
• Peter S, Beglinger C . (2007). Helicobacter pylori and gastric cancer: the causal relationship. Digestion 75: 25–35.
  PubMed Google Scholar
• Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P et al. (2006). Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12: 1–8.
  PubMed Google Scholar
• Pomorski T, Meyer TF, Naumann M . (2001). _Helicobacter pylori_-induced prostaglandin E(2) synthesis involves activation of cytosolic phospholipase A(2) in epithelial cells. J Biol Chem 276: 804–810.
  CAS PubMed Google Scholar
• Potten CS, Booth C, Pritchard DM . (1997). The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 78: 219–243.
  CAS PubMed PubMed Central Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN et al. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359: 235–237.
  CAS PubMed Google Scholar
• Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS . (2005). Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102: 99–104.
  CAS PubMed Google Scholar
• Rad R, Brenner L, Krug A, Voland P, Mages J, Lang R et al. (2007). Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 133: 150–163.
  CAS PubMed Google Scholar
• Rakoff-Nahoum S, Medzhitov R . (2007). Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124–127.
  CAS PubMed Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R . (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229–241.
  CAS PubMed Google Scholar
• Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS . (2002). Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62: 165–170.
  CAS PubMed Google Scholar
• Reddy BS, Narisawa T, Wright P, Vukusich D, Weisburger JH, Wynder EL . (1975). Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35: 287–290.
  CAS PubMed Google Scholar
• Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF . (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95: 588–593.
  CAS PubMed PubMed Central Google Scholar
• Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P et al. (1998). Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273: 28560–28563.
  CAS PubMed Google Scholar
• Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S et al. (2006). Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol 208: 47–54.
  CAS PubMed Google Scholar
• Rumio C, Besusso D, Palazzo M, Selleri S, Sfondrini L, Dubini F et al. (2004). Degranulation of paneth cells via Toll-like receptor 9. Am J Pathol 165: 373–381.
  CAS PubMed PubMed Central Google Scholar
• Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M et al. (2004). Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126: 451–459.
  PubMed Google Scholar
• Sawaoka H, Kawano S, Tsuji S, Tsuji M, Sun W, Gunawan ES et al. (1998). Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 59: 313–316.
  CAS PubMed Google Scholar
• Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Muller-Hermelink HK et al. (2004). Expression and subcellular distribution of Toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136: 521–526.
  CAS PubMed PubMed Central Google Scholar
• Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M . (2005). Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 295: 179–185.
  CAS PubMed Google Scholar
• Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J et al. (1999). IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 276: G1461–G1472.
  CAS PubMed Google Scholar
• Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E et al. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224–5231.
  CAS PubMed PubMed Central Google Scholar
• Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum JR . (1999). Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol 23: 651–655.
  CAS PubMed Google Scholar
• Spechler SJ . (1999). The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 117: 218–228.
  CAS PubMed Google Scholar
• Stolte M, Eidt S . (1989). Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 42: 1269–1271.
  CAS PubMed PubMed Central Google Scholar
• Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668–670.
  CAS PubMed Google Scholar
• Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK et al. (2000). Cyclooxygenase-2 expression in _Helicobacter pylori_-associated premalignant and malignant gastric lesions. Am J Pathol 157: 729–735.
  CAS PubMed PubMed Central Google Scholar
• Suzuki M, Hisamatsu T, Podolsky DK . (2003). Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4–MD-2 complex. Infect Immun 71: 3503–3511.
  CAS PubMed PubMed Central Google Scholar
• Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T . (2006). Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 27: 162–169.
  CAS PubMed Google Scholar
• Suzuki R, Kohno H, Sugie S, Tanaka T . (2005). Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 20: 483–492.
  CAS PubMed Google Scholar
• Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J et al. (1998). Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115: 281–286.
  CAS PubMed Google Scholar
• Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R et al. (2004). Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93: 97–108.
  CAS PubMed Google Scholar
• Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C . (2004a). Crohn's disease is associated with a Toll-like receptor-9 polymorphism. Gastroenterology 127: 365–366.
  PubMed Google Scholar
• Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C . (2004b). Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 112: 85–91.
  CAS PubMed Google Scholar
• Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. (2004). Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5: 1166–1174.
  CAS PubMed Google Scholar
• Wang X, Huycke MM . (2007). Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132: 551–561.
  CAS PubMed Google Scholar
• Wyatt JI, Rathbone BJ . (1988). Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl 142: 44–49.
  CAS PubMed Google Scholar
• Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D et al. (2007). The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26: 461–475.
  CAS PubMed Google Scholar